Using Health Insurance Claims Data to Estimate Epidemiological Indicators: Application Pathways and Key Challenges
Journal of Evidence-Based Medicine · 12.11.2026
DOI: 10.1111/jebm.70210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 12.11.2026. Verfasst von Binchi Liao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guidance Center for Pharmaceutical and Medical Service Pricing and Procurement, National Healthcare Security Administration, Beijing, China. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To synthesize empirical methodological evidence on how health insurance claims data can be converted into prevalence and incidence estimates.
Methods
PubMed and Web of Science Core Collection were searched on July 10, 2026, for reports in English or Chinese published from January 1, 2016, to June 30, 2026. Eligible studies evaluated claims‐based methods for prevalence, incidence, or epidemiological case identification. Data on study context, population definition, case algorithms, numerator/denominator construction, validation, and robustness were extracted, descriptively summarized, and narratively synthesized.
Results
217 studies (217 reports), contributing 331 method instances, met the final methods‐focused criteria. The review found that valid estimation of prevalence and incidence from health insurance claims data depends on population representativeness, accurate case identification, and appropriate data linkage and validation. Methodological choices, including denominator definition, case algorithms, look‐back periods, index‐date rules, and validation sources, substantially influenced estimates.
Conclusions
Valid prevalence and incidence estimation from health insurance claims data requires alignment of the target population, observable membership time, recorded‐disease rule, denominator or disease‐free risk set, and event time or person‐time within the same population and period. Each analytical extract nevertheless requires explicit assessment of coverage, continuity, service capture, coding, and linkage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guidance Center for Pharmaceutical and Medical Service Pricing and Procurement, National Healthcare Security Administration, Beijing, China.
- Health Technology Assessment and Policy Evaluation Group, Renmin University of China, Beijing, China.
- School of Population and Health, Renmin University of China, Beijing, China.
Zitieren
APA
Liao, B., Wang, Z., Li, Y., & Lyu, L. (2026). Using Health Insurance Claims Data to Estimate Epidemiological Indicators: Application Pathways and Key Challenges. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70210
Vancouver
Liao B, Wang Z, Li Y, Lyu L. Using Health Insurance Claims Data to Estimate Epidemiological Indicators: Application Pathways and Key Challenges. Journal of Evidence-Based Medicine. 2026. doi:10.1111/jebm.70210
BibTeX
@article{Liao2026,
author = {Liao, Binchi and Wang, Zhi and Li, Yufei and Lyu, Lanting},
title = {Using Health Insurance Claims Data to Estimate Epidemiological Indicators: Application Pathways and Key Challenges},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
doi = {10.1111/jebm.70210}
}
EUVIMED